About Heat shock 70 kDa protein 13
Heat shock 70 kDa protein 13 (HSPA13) is a protein
from Homo sapiens identified by UniProt accession
P48723, 471 residues long.
MolForge cross-references it against 0 known binders and
44 disease associations.
Target properties
| Protein name | Heat shock 70 kDa protein 13 |
| UniProt accession | P48723 |
| Gene | HSPA13 |
| Organism | Homo sapiens |
| Length | 471 residues |
| Molecular weight | — |
| EC numbers | — |
| Target class | UNCLASSIFIED |
| Subcellular location | — |
| Keywords | — |
Druggability
Target tractability assessment (Open Targets + pocket analysis). No approved drug
| Druggability tier | MEDIUM |
| Druggability score | — |
| Pocket score | — |
| Max clinical phase | — |
Disease associations (44)
Diseases linked to this target (Open Targets).
- diffuse plaque measurement · score 0.23
- breast adenocarcinoma · score 0.18
- pancreatic adenocarcinoma · score 0.10
- hepatocellular carcinoma · score 0.08
- Systemic lupus erythematosus · score 0.04
- Miyoshi myopathy · score 0.03
- neoplasm · score 0.03
- drug use measurement · score 0.02
- visual perception measurement · score 0.02
- dengue disease · score 0.02
3D Structure (1)
Experimental (PDB) and predicted (AlphaFold) structures for this protein.
| Structure | Source | Method | Mean pLDDT | Resolution (Å) |
| AF-P48723-F1 | alphafold | PREDICTED | 87.38 | — |
Amino-acid sequence (471 residues)
MAREMTILGS AVLTLLLAGY LAQQYLPLPT PKVIGIDLGT TYCSVGVFFP GTGKVKVIPD ENGHISIPSM VSFTDNDVYV GYESVELADS NPQNTIYDAK RFIGKIFTAE ELEAEIGRYP FKVLNKNGMV EFSVTSNETI TVSPEYVGSR LLLKLKEMAE AYLGMPVANA VISVPAEFDL KQRNSTIEAA NLAGLKILRV INEPTAAAMA YGLHKADVFH VLVIDLGGGT LDVSLLNKQG GMFLTRAMSG NNKLGGQDFN QRLLQYLYKQ IYQTYGFVPS RKEEIHRLRQ AVEMVKLNLT LHQSAQLSVL LTVEEQDRKE PHSSDTELPK DKLSSADDHR VNSGFGRGLS DKKSGESQVL FETEISRKLF DTLNEDLFQK ILVPIQQVLK EGHLEKTEID EVVLVGGSTR IPRIRQVIQE FFGKDPNTSV DPDLAVVTGV AIQAGIDGGS WPLQVSALEI PNKHLQKTNF N
Explore Heat shock 70 kDa protein 13 with MolForge
Find binders, run structure-based screening, and map this target across
diseases and approved drugs with our AI-powered platform.
Browse all targets